Parisi Gray Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,156
Closed -$200K 114
2024
Q2
$200K Sell
7,156
-586
-8% -$16.1K 0.07% 106
2024
Q1
$215K Sell
7,742
-314
-4% -$8.71K 0.08% 100
2023
Q4
$232K Sell
8,056
-678
-8% -$20.5K 0.09% 94
2023
Q3
$290K Sell
8,734
-155
-2% -$5.48K 0.13% 85
2023
Q2
$363K Buy
8,889
+331
+4% +$12.9K 0.17% 75
2023
Q1
$349K Sell
8,558
-400
-4% -$17.3K 0.22% 64
2022
Q4
$459K Buy
8,958
+670
+8% +$32.1K 0.23% 70
2022
Q3
$363K Sell
8,288
-264
-3% -$12.8K 0.28% 59
2022
Q2
$448K Buy
8,552
+47
+0.6% +$2.4K 0.23% 70
2022
Q1
$440K Sell
8,505
-2
-0% -$104 0.18% 83
2021
Q4
$502K Buy
8,507
+221
+3% +$10.9K 0.19% 83
2021
Q3
$356K Buy
8,286
+56
+0.7% +$2.48K 0.15% 98
2021
Q2
$322K Buy
8,230
+66
+0.8% +$2.57K 0.12% 106
2021
Q1
$296K Sell
8,164
-468
-5% -$16.6K 0.12% 104
2020
Q4
$318K Sell
8,632
-2,262
-21% -$83K 0.14% 99
2020
Q3
$379K Buy
10,894
+2,079
+24% +$72.9K 0.2% 79
2020
Q2
$273K Sell
8,815
-126
-1% -$4.28K 0.16% 93
2020
Q1
$277K Sell
8,941
-907
-9% -$30.9K 0.2% 83
2019
Q4
$366K Sell
9,848
-795
-7% -$28.3K 0.21% 76
2019
Q3
$363K Buy
10,643
+880
+9% +$32K 0.24% 75
2019
Q2
$401K Sell
9,763
-154
-2% -$6.12K 0.27% 72
2019
Q1
$400K Buy
9,917
+574
+6% +$23K 0.26% 73
2018
Q4
$381K Buy
9,343
+210
+2% +$8.72K 0.26% 73
2018
Q3
$380K Sell
9,133
-1,058
-10% -$40.7K 0.23% 82
2018
Q2
$359K Sell
10,191
-445
-4% -$15.2K 0.24% 84
2018
Q1
$343K Sell
10,636
-314
-3% -$10.8K 0.26% 80
2017
Q4
$379K Buy
+10,950
New +$373K 0.28% 78

Other funds holding PFE

Parisi Gray Wealth Management's PFE Position: Q3 2024 in Review

Parisi Gray Wealth Management sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,156 shares — an estimated $200K sold.

Parisi Gray Wealth Management first reported a position in PFE in Q4 2017 and held it in 27 quarters. The position peaked at $502K in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Parisi Gray Wealth Management reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Parisi Gray Wealth Management sold 7,156 Pfizer shares in Q3 2024, an estimated $200K.
  • Parisi Gray Wealth Management first reported a position in Pfizer in Q4 2017 and held it in 27 quarters.
  • Parisi Gray Wealth Management's Pfizer position peaked at $502K in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Parisi Gray Wealth Management's 13F filing for Q3 2024, filed 7 Oct 2024.